Oncotarget

Corrections:

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma

PDF  |  How to cite

Oncotarget. 2018; 9:30024-30024. https://doi.org/10.18632/oncotarget.25776

Metrics: PDF 633 views  |   ?  

Saurabh Agarwal1,*, Giorgio Milazzo2,*, Kimal Rajapakshe3,*, Ronald Bernardi1, Zaowen Chen1, Barbieri Eveline1, Jan Koster4, Giovanni Perini2,**, Cristian Coarfa3,** and Jason M. Shohet1,**

1Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
2Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy
3Dan L Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
4Department of Oncogenomics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
*These authors are considered as co-first authors
**These authors are considered as co-last authors

Published: July 06, 2018

This article has been corrected: The corrected author name is given below:

Barbieri Eveline

Original article: Oncotarget. 2018; 9:20323-20338. DOI: https://doi.org/10.18632/oncotarget.24859.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25776